Taro Pharmaceutical Industries Ltd

Connor, Clark & Lunn Investment Management Ltd.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/9/2024

Shares

14,367

Value ($000)

600

Weight

0.0%

2019 Q4 - 2023 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/9/2024	600	0.0%	14,367	12/31/2023
2023 Q3	11/13/2023	427	0.0%	11,333	9/30/2023
2020 Q2	8/13/2020	374	0.0%	5,623	6/30/2020
2020 Q1	5/13/2020	384	0.0%	6,275	3/31/2020
2019 Q4	2/12/2020	508	0.0%	5,775	12/31/2019